Clostridioides difficile infection (CDI) remains a significant clinical challenge both in the
management of severe and severe-complicated disease and the prevention of recurrence …

Clostridioides (formerly: Clostridium) difficile infection (CDI) is a major cause of diarrhoea for
inpatients as well as outpatients. Usually, CDI is healthcare-associated but the number of …

Metronidazole was until recently used as a first-line treatment for potentially life-threatening
Clostridioides difficile (CD) infection. Although cases of metronidazole resistance have been …

Abstract Background In 2018, the Infectious Diseases Society of America (IDSA) published
guidelines for diagnosis and treatment of Clostridioides (formerly Clostridium) difficile …

Background Vancomycin is now a preferred treatment for all cases of Clostridioides difficile
infection (CDI), regardless of disease severity. Concerns remain that a large-scale shift to …

Clostridioides difficile infection (CDI) is a major enteric disease associated with antibiotic
use and a leading cause of hospital-acquired infections worldwide. This is the first guideline …

Background Metronidazole may still be an appropriate therapeutic option for mild
Clostridium difficile infection (CDI) in select patients, but data are limited to guide clinicians …

Little is known about the role of lineage of strains of Clostridioides difficile (CD) on the
clinical presentation of CD infection (CDI) in Latin America, especially regarding the …

Abstract Objectives The 2017 Society for Healthcare Epidemiology of America (SHEA) and
Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for Clostridioides …

Background Newer antibiotics that specifically target Clostridioides difficile while preserving
the host microbiome have emerged to treat C. difficile infection (CDI): cadazolid, fidaxomicin …